Ultragenyx Pharmaceutical Inc. earnings per share and revenue

RARE earnings per share for the last quarter are -1.40 USD whereas the estimation was -1.48 USD which accounts for 5.66% surprise. Company revenue for the same period amounts to 139.49 M USD despite the estimated figure of 135.28 M USD. Estimated earnings per share for the next quarter are -1.35 USD, and revenue is expected to reach 146.62 M USD. Also watch annual changes over time to get a bigger picture of RARE earnings per share and revenue dynamics.